Fitbit Reports Results of its COVID-19 Study for Early Detection of Diseases

 Fitbit Reports Results of its COVID-19 Study for Early Detection of Diseases

Fitbit Report Results of its COVID-19 Study for Early Detection of Diseases

Shots:

  • In May’2020, Fitbit has launched its COVID-19 study to build an algorithm that detects COVID-19 before symptoms starts. The study has enrolled 1000+ positive patients across the US and Canada is now delivering its first, preliminary results 90 days later
  • The study demonstrated that its devices could detect ~50% of COVID-19 cases one day before participants reported the onset of symptoms such as fever, cough, or muscle aches
  • The algorithm is under development and worked with 70% specificity, or a 30% rate of false positives. The study reinforces that breathing rate, resting heart rate and HRV are all useful metrics for indicating onset of illness and are best tracked at night, when the body is at rest

Click here ­to­ read full press release/ article | Ref: Fibit | Image: Bloomberg

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post